Gloria Garoffolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gloria Garoffolo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Maurizio Pesce
Unità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy
11 shared publications - Giacomo Bernava
University of Padua
3 shared publications - Gualtiero Ivanoe Colombo
Centro Cardiologico Monzino, IRCCS, Milan, Italy
3 shared publications Franca Scocozza
Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy
2 shared publicationsMichele Conti
Department of Civil Engineering and Architecture, University of Pavia, Pavia, Italy
2 shared publications- Sara Ragazzini
Centro Cardiologico Monzino, IRCCS, Unità di Ingegneria Tissutale Cardiovascolare, Via C. Parea, 4, Milan I-20138, Italy
2 shared publications
Latest Publications
- Open Access
Mechanosensitive Non-Coding RNAs in Cardiovascular Disease: Mechanisms, Therapeutic Targeting and Cardiac Delivery
Non-coding RNAs (ncRNAs) have emerged as major regulators of gene expression and cellular homeostasis, with growing evidence supporting their involvement in cardiovascular physiology and disease. This review summarizes the classification, mechanisms of action, and functional roles of ncRNAs, with particular focus on mechano-ncRNAs involved in cardiovascular remodeling and fibrosis. Different classes of ncRNAs are discussed in relation to their contributions to vascular, valvular, and myocardial homeostasis, as well as to pathological processes including inflammation, endothelial dysfunction, and fibrotic responses. Special emphasis is placed on biomechanical stimuli, including increased matrix stiffness, cyclic strain, and altered shear stress, which can modulate ncRNA expression and activity through mechanotransduction pathways. Notable examples of mechano-ncRNAs include miR-21, miR-29, miR-132, MIAT, MALAT1, and MEG3, which have been implicated in maladaptive cardiac remodeling and fibrosis. Concurrently, we highlight the importance of technical advances in ncRNA discovery and cardiac-specific delivery systems, including viral and nanoparticle-based vectors, for the development of ncRNA-based therapeutic strategies with potential for clinical translation. Overall, ncRNAs are shown to represent promising biomarkers and therapeutic targets in cardiovascular diseases, particularly in mechanically driven pathological conditions. However, challenges related to delivery specificity, stability, off-target effects, and safety remain and will need to be addressed to enable the clinical translation of ncRNA-based therapies in precision cardiovascular medicine.
Open AccessMechanosensitive Non-Coding RNAs in Cardiovascular Disease: Mechanisms, Therapeutic Targeting and Cardiac Delivery
Non-coding RNAs (ncRNAs) have emerged as major regulators of gene expression and cellular homeostasis, with growing evidence supporting their involvement in cardiovascular physiology and disease. This review summarizes the classification, mechanisms of action, and functional roles of ncRNAs, with particular focus on mechano-ncRNAs involved in cardiovascular remodeling and fibrosis. Different classes of ncRNAs are discussed in relation to their contributions to vascular, valvular, and myocardial homeostasis, as well as to pathological processes including inflammation, endothelial dysfunction, and fibrotic responses. Special emphasis is placed on biomechanical stimuli, including increased matrix stiffness, cyclic strain, and altered shear stress, which can modulate ncRNA expression and activity through mechanotransduction pathways. Notable examples of mechano-ncRNAs include miR-21, miR-29, miR-132, MIAT, MALAT1, and MEG3, which have been implicated in maladaptive cardiac remodeling and fibrosis. Concurrently, we highlight the importance of technical advances in ncRNA discovery and cardiac-specific delivery systems, including viral and nanoparticle-based vectors, for the development of ncRNA-based therapeutic strategies with potential for clinical translation. Overall, ncRNAs are shown to represent promising biomarkers and therapeutic targets in cardiovascular diseases, particularly in mechanically driven pathological conditions. However, challenges related to delivery specificity, stability, off-target effects, and safety remain and will need to be addressed to enable the clinical translation of ncRNA-based therapies in precision cardiovascular medicine.
- 3 December 2024
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 120 (17) , 2158-2159
When cell mechanics meets epitranscriptomics: reduction of m6A in Piezo2 RNA ameliorates cardiac fibrosis
- 3 December 2024
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 120 (17) , 2158-2159
When cell mechanics meets epitranscriptomics: reduction of m6A in Piezo2 RNA ameliorates cardiac fibrosis
- Open Access
- 10 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3398
Cells and Materials for Cardiac Repair and Regeneration
After more than 20 years following the introduction of regenerative medicine to address the problem of cardiac diseases, still questions arise as to the best cell types and materials to use to obtain effective clinical translation. Now that it is definitively clear that the heart does not have a consistent reservoir of stem cells that could give rise to new myocytes, and that there are cells that could contribute, at most, with their pro-angiogenic or immunomodulatory potential, there is fierce debate on what will emerge as the winning strategy. In this regard, new developments in somatic cells’ reprogramming, material science and cell biophysics may be of help, not only for protecting the heart from the deleterious consequences of aging, ischemia and metabolic disorders, but also to boost an endogenous regeneration potential that seems to be lost in the adulthood of the human heart.
- 10 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3398
Open AccessCells and Materials for Cardiac Repair and Regeneration
After more than 20 years following the introduction of regenerative medicine to address the problem of cardiac diseases, still questions arise as to the best cell types and materials to use to obtain effective clinical translation. Now that it is definitively clear that the heart does not have a consistent reservoir of stem cells that could give rise to new myocytes, and that there are cells that could contribute, at most, with their pro-angiogenic or immunomodulatory potential, there is fierce debate on what will emerge as the winning strategy. In this regard, new developments in somatic cells’ reprogramming, material science and cell biophysics may be of help, not only for protecting the heart from the deleterious consequences of aging, ischemia and metabolic disorders, but also to boost an endogenous regeneration potential that seems to be lost in the adulthood of the human heart.
- Open Access
Relevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Severe coagulopathy has been observed at the level of the microcirculation in several organs including lungs, heart and kidneys in patients with COVID-19, and in a minority of subjects receiving the SARS-CoV-2 vaccine. Various mechanisms have been implicated in these effects, including increases in circulating neutrophil extracellular traps, excessive inflammation, and endothelial dysfunction. Even if a correlation between infection by SARS-CoV-2 and upregulation of coagulation cascade components has been established in the lung, no direct proofs have been yet provided about the transcriptional machinery controlling the expression of these factors. Recent results obtained by us reported a novel transcriptional function of the SARS-CoV-2 Spike (S) viral protein involving a direct protein-protein interaction with the human Estrogen Receptor-α (ERα). Given the implications of ERα in the control of key effectors in the coagulation cascade, we hypothesized that S-protein might increase the pro-coagulation activity of endothelial cells via the transcriptional activity of the ERα, thus justifying the enhanced risk of thrombosis. To assess this, we tested the effects of S-protein on the expression of Tissue Factor (TF) and the overall procoagulation activity in a human endothelial cell line and confirmed this finding by overexpressing S-protein by gene transfer in mice. We then designed and tested two-point mutations in the S2 S-protein sequence that abolished the pro-coagulation function of S-protein in vitro and in vivo , without compromising its immunogenicity. In addition to reveal a new potential transcriptional function of S-protein, these results inspire the design of new vaccines with lower risk of thrombogenesis. Indeed, while the benefit/risk ratio remains overwhelming in favor of COVID-19 vaccination, our results shed light on the causal mechanisms of some rare anti-SARS-CoV-2 vaccine adverse events, and are thus essential for current and future vaccination and booster campaigns.
Open AccessRelevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Severe coagulopathy has been observed at the level of the microcirculation in several organs including lungs, heart and kidneys in patients with COVID-19, and in a minority of subjects receiving the SARS-CoV-2 vaccine. Various mechanisms have been implicated in these effects, including increases in circulating neutrophil extracellular traps, excessive inflammation, and endothelial dysfunction. Even if a correlation between infection by SARS-CoV-2 and upregulation of coagulation cascade components has been established in the lung, no direct proofs have been yet provided about the transcriptional machinery controlling the expression of these factors. Recent results obtained by us reported a novel transcriptional function of the SARS-CoV-2 Spike (S) viral protein involving a direct protein-protein interaction with the human Estrogen Receptor-α (ERα). Given the implications of ERα in the control of key effectors in the coagulation cascade, we hypothesized that S-protein might increase the pro-coagulation activity of endothelial cells via the transcriptional activity of the ERα, thus justifying the enhanced risk of thrombosis. To assess this, we tested the effects of S-protein on the expression of Tissue Factor (TF) and the overall procoagulation activity in a human endothelial cell line and confirmed this finding by overexpressing S-protein by gene transfer in mice. We then designed and tested two-point mutations in the S2 S-protein sequence that abolished the pro-coagulation function of S-protein in vitro and in vivo , without compromising its immunogenicity. In addition to reveal a new potential transcriptional function of S-protein, these results inspire the design of new vaccines with lower risk of thrombogenesis. Indeed, while the benefit/risk ratio remains overwhelming in favor of COVID-19 vaccination, our results shed light on the causal mechanisms of some rare anti-SARS-CoV-2 vaccine adverse events, and are thus essential for current and future vaccination and booster campaigns.
- 31 August 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 152, 300-312
Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis
- 31 August 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 152, 300-312
Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis
- Open Access
- 1 June 2022
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 118 (Supplement)
Mechanical activation of Hippo/TGFb pathways lead human saphenous vein progenitors toward pro-fibrotic differentiation in aorto-coronary bypass failure
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ricerca Corrente Introduction: We previously demonstrated that mechanical stress deriving from coronary flow/pressure patterns in the human saphenous vein (SV) conduits induce release of Thrombospondin-1 (TSP-1) by smooth muscle cells, and this activates adventitial progenitors (SVPs) pathologic activation. Purpose: In this study, we show a cooperation of the TGF-β/TSP-1 signaling with the mechanically-activated Hippo transcriptional pathway in fibrotic SVPs commitment. Methods: Human derived-SVPs were isolated using a MACS based protocol with a positive selection for CD34 and a negative depletion of CD31+ cells. We performed an RNA-seq analysis of SVPs subjected to 10% uniaxial deformation (n=5), followed by differential gene expression and pathway analyses. We validated results in vitro and in two animal models of vein arterialization. Results: A response of SVPs to mechanical stimulation was assessed from variations in cell alignment, circularity and area. The susceptibility of SVPs to uniaxial strain was revealed by a trend of the cells to orientate in orthogonal direction to the strain field and changes in cell shape. Mechanically stimulated cells for 72 hrs showed a significant increase in their motility as verified by migration assays in the presence of medium supplemented with 10% serum. RNA-seq analysis of the total transcriptome expressed in these cells with/without mechanical stimulation was performed. The differentially expressed genes (DEGs) analysis highlighted a maximum variation of the transcriptome at 72hrs of mechanical stimulation vs. static controls with n=819 DEGs. A gene enrichment analysis revealed an involvement of the HIPPO/YAP/TEAD and of the TGF-β/SMAD transcriptional circuitries in mechanically-stimulated cells. In keeping, immunofluorescence and RT-qPCR showed an increase in YAP nuclear translocation and activity. We treated cells with a cytoskeleton inhibitor (Forskolin, FRSK) and a drug (Verteporfin, VTP) that prevents the interaction of the YAP/TAZ complex with TEADs. Both drugs inhibited expression of YAP-transcriptional targets and cellular motility in response to serum. We then treated cells with TGF-β1, TSP-1 alone or in combination. Under these conditions we observed an increased expression of YAP targets and CollA1, a higher amount of Collagen secretion in the supernatant and a higher association of YAP with pSMAD3. All these effects were blunted by VTP. YAP nuclear localization was finally validated in two models of vein arterialization in mice and pigs. Conclusions: Our data suggest a convergent activation of Hippo/TGF-β pathways in the failure of the aorto-coronary bypass and highlight a future novel strategy to limit its progression in patients.
- 1 June 2022
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 118 (Supplement)
Open AccessMechanical activation of Hippo/TGFb pathways lead human saphenous vein progenitors toward pro-fibrotic differentiation in aorto-coronary bypass failure
Funding Acknowledgements: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ricerca Corrente Introduction: We previously demonstrated that mechanical stress deriving from coronary flow/pressure patterns in the human saphenous vein (SV) conduits induce release of Thrombospondin-1 (TSP-1) by smooth muscle cells, and this activates adventitial progenitors (SVPs) pathologic activation. Purpose: In this study, we show a cooperation of the TGF-β/TSP-1 signaling with the mechanically-activated Hippo transcriptional pathway in fibrotic SVPs commitment. Methods: Human derived-SVPs were isolated using a MACS based protocol with a positive selection for CD34 and a negative depletion of CD31+ cells. We performed an RNA-seq analysis of SVPs subjected to 10% uniaxial deformation (n=5), followed by differential gene expression and pathway analyses. We validated results in vitro and in two animal models of vein arterialization. Results: A response of SVPs to mechanical stimulation was assessed from variations in cell alignment, circularity and area. The susceptibility of SVPs to uniaxial strain was revealed by a trend of the cells to orientate in orthogonal direction to the strain field and changes in cell shape. Mechanically stimulated cells for 72 hrs showed a significant increase in their motility as verified by migration assays in the presence of medium supplemented with 10% serum. RNA-seq analysis of the total transcriptome expressed in these cells with/without mechanical stimulation was performed. The differentially expressed genes (DEGs) analysis highlighted a maximum variation of the transcriptome at 72hrs of mechanical stimulation vs. static controls with n=819 DEGs. A gene enrichment analysis revealed an involvement of the HIPPO/YAP/TEAD and of the TGF-β/SMAD transcriptional circuitries in mechanically-stimulated cells. In keeping, immunofluorescence and RT-qPCR showed an increase in YAP nuclear translocation and activity. We treated cells with a cytoskeleton inhibitor (Forskolin, FRSK) and a drug (Verteporfin, VTP) that prevents the interaction of the YAP/TAZ complex with TEADs. Both drugs inhibited expression of YAP-transcriptional targets and cellular motility in response to serum. We then treated cells with TGF-β1, TSP-1 alone or in combination. Under these conditions we observed an increased expression of YAP targets and CollA1, a higher amount of Collagen secretion in the supernatant and a higher association of YAP with pSMAD3. All these effects were blunted by VTP. YAP nuclear localization was finally validated in two models of vein arterialization in mice and pigs. Conclusions: Our data suggest a convergent activation of Hippo/TGF-β pathways in the failure of the aorto-coronary bypass and highlight a future novel strategy to limit its progression in patients.
- Open Access
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Mechanosensor YAP Cooperates with TGF-Β1 Signaling to Promote Myofibroblast Differentiation and Matrix Stiffening in a 3d Model of Human Cardiac Fibrosis
Cardiac fibrosis is characterized by a maladaptive remodeling of the myocardium, which is controlled by various inflammatory pathways and cytokines. This remodeling is accompanied by a significant stiffening of the matrix, which may contribute to further activate collagen synthesis and scar formation. Evidence suggests that TGF-β1 signaling, the main pro-fibrotic pathway in cardiac fibrosis, might cooperates with the Hippo transcriptional pathway by activating YAP/TAZ. To directly test the cooperation of mechanical cues and paracrine signaling in cardiac fibrosis, we developed a 3D model of cardiac extracellular matrix remodeling by generating tissue blocks with Gelatin Methacrylate, a bioink with tunable stiffness, and human cardiosphere-derived stromal cells. Using this strategy, we assessed the cooperation of TGF-β1 and YAP/TAZ transcriptional complex to matrix compaction. Using mechanical compression tests, Masson’s trichrome staining, immunofluorescence, and RT-qPCR, we demonstrate that pharmacological inhibition of YAP/TAZ complex reverts almost completely the pro-compaction phenotype and the matrix-remodeling activity of cells treated with TGF-β1. Our data show a direct connection between the classical pro-fibrotic signaling driven by TGF-β1 and the mechanically activated pathways under the control of YAP/TAZ in cardiac remodeling. Treatment with the elective drug targeting YAP/TAZ is sufficient to override this cooperation with potential benefits for anti-fibrotic therapeutic applications. Funding Information: This work was supported by Institutional grants (Ricerca Corrente, 5 per 1000) issued by the Italian Ministry of Health to M.P. Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: The use of human cardiac stromal cells was performed after authorization by the local ethical committee at Centro Cardiologico Monzino (approval date: 19 May 2012 and subsequent renewal on 16 May 2016) and have been performed in compliance with the Declaration of Helsinki. Patients signed an informed consent authorizing the donation of small fragments of cardiac tissue for research scopes.
- 1 January 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessMechanosensor YAP Cooperates with TGF-Β1 Signaling to Promote Myofibroblast Differentiation and Matrix Stiffening in a 3d Model of Human Cardiac Fibrosis
Cardiac fibrosis is characterized by a maladaptive remodeling of the myocardium, which is controlled by various inflammatory pathways and cytokines. This remodeling is accompanied by a significant stiffening of the matrix, which may contribute to further activate collagen synthesis and scar formation. Evidence suggests that TGF-β1 signaling, the main pro-fibrotic pathway in cardiac fibrosis, might cooperates with the Hippo transcriptional pathway by activating YAP/TAZ. To directly test the cooperation of mechanical cues and paracrine signaling in cardiac fibrosis, we developed a 3D model of cardiac extracellular matrix remodeling by generating tissue blocks with Gelatin Methacrylate, a bioink with tunable stiffness, and human cardiosphere-derived stromal cells. Using this strategy, we assessed the cooperation of TGF-β1 and YAP/TAZ transcriptional complex to matrix compaction. Using mechanical compression tests, Masson’s trichrome staining, immunofluorescence, and RT-qPCR, we demonstrate that pharmacological inhibition of YAP/TAZ complex reverts almost completely the pro-compaction phenotype and the matrix-remodeling activity of cells treated with TGF-β1. Our data show a direct connection between the classical pro-fibrotic signaling driven by TGF-β1 and the mechanically activated pathways under the control of YAP/TAZ in cardiac remodeling. Treatment with the elective drug targeting YAP/TAZ is sufficient to override this cooperation with potential benefits for anti-fibrotic therapeutic applications. Funding Information: This work was supported by Institutional grants (Ricerca Corrente, 5 per 1000) issued by the Italian Ministry of Health to M.P. Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: The use of human cardiac stromal cells was performed after authorization by the local ethical committee at Centro Cardiologico Monzino (approval date: 19 May 2012 and subsequent renewal on 16 May 2016) and have been performed in compliance with the Declaration of Helsinki. Patients signed an informed consent authorizing the donation of small fragments of cardiac tissue for research scopes.
- Open Access
- 29 June 2021
- Published by Bioscientifica in Vascular Biology
- Vol. 3 (1) , R69-R75
Vascular dysfunction and pathology: focus on mechanical forces
The role of mechanical forces is emerging as a new player in the pathophysiologic programming of the cardiovascular system. The ability of the cells to ‘sense’ mechanical forces does not relate only to perception of movement or flow, as intended traditionally, but also to the biophysical properties of the extracellular matrix, the geometry of the tissues, and the force distribution inside them. This is also supported by the finding that cells can actively translate mechanical cues into discrete gene expression and epigenetic programming. In the present review, we will contextualize these new concepts in the vascular pathologic programming.
- 29 June 2021
- Published by Bioscientifica in Vascular Biology
- Vol. 3 (1) , R69-R75
Open AccessVascular dysfunction and pathology: focus on mechanical forces
The role of mechanical forces is emerging as a new player in the pathophysiologic programming of the cardiovascular system. The ability of the cells to ‘sense’ mechanical forces does not relate only to perception of movement or flow, as intended traditionally, but also to the biophysical properties of the extracellular matrix, the geometry of the tissues, and the force distribution inside them. This is also supported by the finding that cells can actively translate mechanical cues into discrete gene expression and epigenetic programming. In the present review, we will contextualize these new concepts in the vascular pathologic programming.
- Open Access
- 25 May 2021
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 2, 100036
From dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure
- 25 May 2021
- Published by Elsevier in Current Research in Pharmacology and Drug Discovery
- Vol. 2, 100036
Open AccessFrom dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure
- Open Access
- 10 March 2021
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 117 (6) , 1557-1566
Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression
Patients with severe respiratory syndrome caused by SARS-CoV-2 undergo cardiac complications due to hyper-inflammatory conditions. Although the presence of the virus has been detected in the myocardium of infected patients, and infection of induced pluripotent cell-derived cardiomyocytes has been demonstrated, the reported expression of Angiotensin-Converting Enzyme-2 (ACE2) in cardiac stromal cells suggests that SARS-CoV-2 may determine cardiac injury by sustaining productive infection and increasing inflammation. We analysed expression of ACE2 receptor in primary human cardiac stromal cells derived from cardiospheres, using proteomics and transcriptomics before exposing them to SARS-CoV-2 in vitro. Using conventional and high sensitivity PCR methods, we measured virus release in the cellular supernatants and monitored the intracellular viral bioprocessing. We performed high-resolution imaging to show the sites of intracellular viral production and demonstrated the presence of viral particles in the cells with electron microscopy. We finally used RT–qPCR assays to detect genes linked to innate immunity and fibrotic pathways coherently regulated in cells after exposure to the virus. Our findings indicate that cardiac stromal cells are susceptible to SARS-CoV-2 infection and produce variable viral yields depending on the extent of cellular ACE2 receptor expression. Interestingly, these cells also evolved towards hyper-inflammatory/pro-fibrotic phenotypes independently of ACE2 levels. Thus, SARS-CoV-2 infection of myocardial stromal cells could be involved in cardiac injury and explain the high number of complications observed in severe cases of COVID-19.
- 10 March 2021
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 117 (6) , 1557-1566
Open AccessHuman cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression
Patients with severe respiratory syndrome caused by SARS-CoV-2 undergo cardiac complications due to hyper-inflammatory conditions. Although the presence of the virus has been detected in the myocardium of infected patients, and infection of induced pluripotent cell-derived cardiomyocytes has been demonstrated, the reported expression of Angiotensin-Converting Enzyme-2 (ACE2) in cardiac stromal cells suggests that SARS-CoV-2 may determine cardiac injury by sustaining productive infection and increasing inflammation. We analysed expression of ACE2 receptor in primary human cardiac stromal cells derived from cardiospheres, using proteomics and transcriptomics before exposing them to SARS-CoV-2 in vitro. Using conventional and high sensitivity PCR methods, we measured virus release in the cellular supernatants and monitored the intracellular viral bioprocessing. We performed high-resolution imaging to show the sites of intracellular viral production and demonstrated the presence of viral particles in the cells with electron microscopy. We finally used RT–qPCR assays to detect genes linked to innate immunity and fibrotic pathways coherently regulated in cells after exposure to the virus. Our findings indicate that cardiac stromal cells are susceptible to SARS-CoV-2 infection and produce variable viral yields depending on the extent of cellular ACE2 receptor expression. Interestingly, these cells also evolved towards hyper-inflammatory/pro-fibrotic phenotypes independently of ACE2 levels. Thus, SARS-CoV-2 infection of myocardial stromal cells could be involved in cardiac injury and explain the high number of complications observed in severe cases of COVID-19.